Friday, May 23, 2008

Research Needed on How Consumer Risk Behavior is Impacted by Pharma DTC!

An FDA panel of experts has concluded that more research needs to be done on ads for prescriptions drugs and their effect on consumer behavior.

According to Kristin Davis, deputy director for the FDA's Division of Drug Marketing, Advertising and Communications 68,000 marketing campaigns including commercials and print ads, magnets and pens, were submitted to the FDA.

A study from the National Institutes of Health found thatin 2005, $29.9 billion was spent on advertising, free samples, and sales staff to promote brand name products. More than $4 billion were spent on DTC ads versus $429 million for ads for doctors.

Read more...

No comments: